GSE196117 6 V 8 CLARITHROMYCIN HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE196117 6 V 8 CLARITHROMYCIN HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE196117 6 V 8 CLARITHROMYCIN HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE196117 6 V 8 CLARITHROMYCIN HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE196117 6 V 8 CLARITHROMYCIN HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

notch 2 N-terminal like B

Gene

olfactory receptor family 14 subfamily J member 1

Gene

trimethyllysine hydroxylase, epsilon

Gene

heterogeneous nuclear ribonucleoprotein L like

Gene

serpin family A member 10

Gene

zinc finger protein 254

Gene

bridge-like lipid transfer protein family member 3B

Gene

R-spondin 3

Gene

solute carrier family 49 member 4

Gene

C-type lectin domain family 12 member B

  • Gene

    notch 2 N-terminal like B


  • Gene

    olfactory receptor family 14 subfamily J member 1


  • Gene

    trimethyllysine hydroxylase, epsilon


  • Gene

    heterogeneous nuclear ribonucleoprotein L like


  • Gene

    serpin family A member 10


  • Gene

    zinc finger protein 254


  • Gene

    bridge-like lipid transfer protein family member 3B



  • Gene

    solute carrier family 49 member 4


  • Gene

    C-type lectin domain family 12 member B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.